Criteria to Initiate Fast-Acting Insulin with Meals in Pregnancy
Initiate rapid-acting (prandial) insulin when postprandial glucose targets are not achieved with basal insulin alone or with nutrition therapy, specifically when 1-hour postprandial glucose exceeds 140 mg/dL or 2-hour postprandial glucose exceeds 120 mg/dL. 1
Glycemic Targets That Trigger Prandial Insulin
The decision to add mealtime insulin is driven by failure to meet pregnancy-specific postprandial targets:
- Fasting glucose: 70-95 mg/dL (3.9-5.3 mmol/L)
- 1-hour postprandial: 110-140 mg/dL (6.1-7.8 mmol/L), OR
- 2-hour postprandial: 100-120 mg/dL (5.6-6.7 mmol/L) 1
When postprandial monitoring reveals consistent elevations above these thresholds despite optimal basal insulin and nutrition therapy, rapid-acting insulin at meals becomes necessary. Postprandial monitoring is specifically associated with better glycemic outcomes and lower risk of preeclampsia compared to preprandial monitoring alone 1.
Clinical Algorithm for Initiation
Step 1: Optimize Nutrition First
- Begin with medical nutrition therapy emphasizing nutrient-dense foods, limiting processed foods and sweetened beverages 1
- For gestational diabetes, attempt 1-2 weeks of nutrition therapy before adding insulin 2
Step 2: Add Basal Insulin if Fasting Glucose Elevated
- If fasting glucose consistently >95 mg/dL despite nutrition therapy, initiate long-acting basal insulin first 2
- Titrate basal insulin using fasting glucose values 3
Step 3: Add Prandial Insulin When Postprandial Targets Missed
Initiate rapid-acting insulin at specific meals when:
- Postprandial glucose exceeds targets at that meal despite adequate basal insulin
- Pattern emerges over 3-5 days of elevated postprandial values 2
- The meal causing elevation determines which dose(s) to add (breakfast, lunch, dinner) 2
Step 4: Monitor and Titrate
- Require 6-7 blood glucose measurements daily for proper insulin adjustment 4
- Use preprandial testing when on basal-bolus therapy to adjust premeal rapid-acting doses 1
- Postprandial values guide prandial insulin titration 3
Insulin Physiology Considerations
Around 16 weeks gestation, insulin resistance increases substantially, often doubling total daily insulin requirements by week 36. 1 This physiologic change frequently necessitates adding prandial insulin even when earlier pregnancy was controlled with basal insulin alone. The increasing insulin resistance makes postprandial hyperglycemia particularly difficult to control without mealtime insulin coverage.
Type of Rapid-Acting Insulin
Rapid-acting insulin analogues (lispro, aspart) are preferred over regular insulin because they:
- Better control postprandial hyperglycemia 5, 6
- Reduce risk of delayed hypoglycemia 3
- Can be administered 0-15 minutes before meals 3
- Do not transfer across the placenta 6
Common Pitfalls to Avoid
Do not wait for A1C elevation to add prandial insulin. A1C represents average glucose and may miss significant postprandial excursions that drive adverse outcomes. The HAPO study demonstrated that increasing glycemia levels, even within normal A1C range, associate with worsening pregnancy outcomes 1.
**Do not use a single CGM target of <140 mg/dL instead of distinct fasting and postprandial targets.** The 2025 Endocrine Society guideline specifically recommends against this approach, as fasting glucose >126 mg/dL associates with adverse outcomes that a single target may miss 7.
Avoid undertreating postprandial hyperglycemia. Postprandial glucose is predictive of adverse pregnancy outcomes and requires specific targeting with mealtime insulin when elevated 6.
Special Populations
For type 2 diabetes on insulin: The 2025 Endocrine Society guideline suggests against routinely adding metformin to insulin, as potential harm (increased small-for-gestational-age infants) may outweigh benefits 7.
For type 1 diabetes: Most will require basal-bolus therapy from diagnosis/conception, with prandial insulin as part of initial regimen 1, 3.